Degron Therapeutics vs Gossamer Bio
Degron Therapeutics vs Gossamer Bio, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Degron Therapeutics is on 62/100 and Gossamer Bio on 54/100.
Where each one leads
Degron Therapeutics
- our overall score: 62/100 against 54/100
Gossamer Bio
- agent readiness: 47/100 against 27/100
- domain rating: 49/100 against 25/100
- headcount: 154 against 24
- funding raised: $150M against $40.0M
- LinkedIn following: 14,489 against 1,380
At a glance
| Measure | Degron Therapeutics | Gossamer Bio |
|---|---|---|
| What it is | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. | A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2017 |
| Headquarters | San Diego, USA | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Degron Therapeutics | Gossamer Bio |
|---|---|---|
| Employees | 24 | 154 |
| Total funding | $40.0M | $150M |
| Latest round | Series A Extension | Series B |
| Valuation | $1.1B | $1.1B |
| LinkedIn followers | 1,380 | 14,489 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Degron Therapeutics | Gossamer Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 54/100 |
| Traction | Not published | 60/100 |
| Team | 24/100 | Not published |
| Search visibility | 57/100 | 30/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (27/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 49/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Degron Therapeutics | Gossamer Bio |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager |
Degron Therapeutics vs Gossamer Bio: common questions
Which is better, Degron Therapeutics or Gossamer Bio?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Degron Therapeutics and Gossamer Bio compare on the numbers?
Degron Therapeutics leads on our overall score (62/100 against 54/100). Gossamer Bio leads on agent readiness (47/100 against 27/100), domain rating (49/100 against 25/100), headcount (154 against 24), funding raised ($150M against $40.0M), LinkedIn following (14,489 against 1,380).
Read the full Degron Therapeutics review and pricing or the Gossamer Bio review and pricing. You can also browse other Degron Therapeutics alternatives we track.